GLP-1 receptor agonists mimic a natural hormone to lower blood sugar and support weight management. Primarily used for type 2 diabetes, these injectable medications slow digestion and reduce appetite. Patients with obesity or cardiovascular risks often benefit, as they improve glycemic control and promote sustainable weight loss when combined with lifestyle changes.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·This Month's Top Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends